Comparison of Effectiveness of Ranolazine Plus Amiodarone Versus Amiodarone Alone for Conversion of Recent-Onset Atrial Fibrillation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of Effectiveness of Ranolazine Plus Amiodarone Versus Amiodarone Alone for Conversion of Recent-Onset Atrial Fibrillation

Published:2012-09 Issue:5 Volume:110 Page:673-677
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Fragakis Nikolaos,Koskinas Konstantinos C.,Katritsis Demosthenes G.,Pagourelias Efstathios D.,Zografos Theodoros,Geleris Paraschos

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC);Camm;Eur Heart J,2010

2. Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches;Savelieva;Europace,2008

3. A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation;Kochiadakis;Am J Cardiol,2007

4. Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study;Vardas;Chest,2000

5. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties;Antzelevitch;Circulation,2004

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ranolazine Unveiled: Rediscovering an Old Solution in a New Light;Journal of Clinical Medicine;2024-08-23

2. Safety and Effectiveness of Antidysrhythmic Drugs for Pharmacologic Cardioversion of Recent-Onset Atrial Fibrillation: a Systematic Review and Bayesian Network Meta-analysis;Cardiovascular Drugs and Therapy;2024-02-07

3. Experimental drugs for supraventricular tachycardia: an analysis of early phase clinical trials;Expert Opinion on Investigational Drugs;2023-09-02

4. Bayesian Network Meta-analysis of Randomized Controlled Trials on the Efficacy of Antiarrhythmics in the Pharmacological Cardioversion of Paroxysmal Atrial Fibrillation;American Journal of Cardiovascular Drugs;2023-05-26

5. Structural basis for inhibition of the cardiac sodium channel by the atypical antiarrhythmic drug ranolazine;Nature Cardiovascular Research;2023-05-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3